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The thymus is the main organ of the lymphatic system, in which T cells undergo a
rigorous selection to ensure that their receptors (TCRs) will be functional and will not react
against the self. Genes encoding for TCR chains are fragmented and must be rearranged
by a process of somatic recombination generating TCR rearrangement excision circles
(TRECs). We recently documented coxsackievirus B4 (CV-B4) infection of Swiss albino
mouse thymus in the course of in utero transmission. In the current study, we intended
to evaluate thymic output in this experimental model. For this purpose, pregnant Swiss
albino mice were inoculated with CV-B4 at day 10 or 17 of gestation, and thymus
and spleen were sampled from offspring at different time points and then subjected
to quantification of TREC molecules and Ptk7 gene expression. Results showed a
pronounced effect of in utero CV-B4 infection on the thymus with an increase in the
cellularity and, consequently, the weight of the organ. sj and DβTREC analysis, by
real-time PCR, revealed a significant decrease following CV-B4 infection compared to
controls, a decrease which gets worse as time goes by, both in the thymus and in
the periphery. Those observations reflect a disturbance in the export of T cells to the
periphery and their accumulation within the thymus. The evaluation of Ptk7 transcripts
in the thymus, for its part, showed a decrease in expression, especially following an
infection at day 10 of gestation, which supports the hypothesis of T cell accumulation in
a mature stage in the thymus. The various effects observed correlate either negatively or
positively with the viral load in the thymus and spleen. Disruption in thymic export may
indeed interfere with T cell maturation. We speculate that this may lead to a premature
release of T cells and the possibility of circulating autoreactive or proliferation-impaired T
cell clones.
Keywords: thymus, T cell, thymic export, T cell receptor (TCR) rearrangement excision circles, autoimmune
diseases, Ptk7 gene, coxsackievirus B, vertical transmission
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INTRODUCTION
The thymus is an asymmetrical bilobate gland localized in the
upper chest region above the pericardium of the heart and arises
from the third pharyngeal pouch of the endoderm [reviewed by
Blackburn and Manley (1)]. The thymus is a primary lymphoid
organ, in which T lymphocytes or T cells undergo a rigorous
selection to ensure that they will not react against the self and
that their receptors are functional. This process of maturation
and education of thymocytes (intrathymic T cells) consists of the
expression of a functional T cell receptor (TCR) on lymphoid
precursors from the bone marrow (BM) and fetal liver to result
in the formation of mature T cells (so-called naive) that gain
the periphery [reviewed by Zhang and Bhandoola (2)]. TCRα
and β-chain gene are composed of Variable (V), Diversity (D,
only in TCR β-chain gene), and Joining (J) gene segments. This
process called V(D)J recombination takes place in the thymus
during the maturation of lymphocyte precursors and involves
enzymes expressed only in lymphocytes, the recombination-
activating genes (RAG)-1 and RAG-2 (3). The β-chain gene
rearrangement occurs first and begins at the double negative
(DN) 2 stage. It requires the successful recombination of D and J
gene segments, followed by V to DJ gene segment recombination
(3). The rearrangement of the TCR α-chain locus occurs at the
double positive (DP) stage (3).
Excisional rearrangements of TCR genes in thymocytes
generate episomal DNA circles produced in thymocytes and
called TCR rearrangement excision circles (TRECs). TRECs are
stable, not replicated during mitosis, progressively diluted with
cell division, and therefore enriched in thymocytes, recent thymic
emigrants (RTEs), and naive T cells (4).
TRECs are formed during any TCR gene rearrangement, but
classically only two types are quantified to assess thymic function:
DJβTRECs (also called DβTRECs) formed during β chain
rearrangement and sjTRECs created by the excision of the δ locus
located inside the α-chain locus (5). As sjTRECs are produced
at the DP stage, they are found in almost each cell leaving
the thymus, known as RTEs, and are therefore a good marker
of the quantity of cells exported by the thymus. Conversely,
DβTRECs are generated just before the intensive proliferation
phase (5). By calculating the ratio of sj/Dβ TRECs, the extent of
this intrathymic proliferation can thus be assessed (6).
TRECs have been considered for a long time as the best tool to
investigate thymic function (7). Recently, protein tyrosine kinase
7 (PTK7), also known as colon carcinoma kinase-4, has been
identified as a novel surface marker for RTEs (8). Intrathymic
PTK7 expression progressively decreases with maturation until
it is lost on mature SP CD8T cells before and on SP CD4T cells
shortly after exportation (8–10).
A reduced thymic activity was one of the common clinical
features in patients suffering from different autoimmune
diseases, namely, rheumatoid arthritis (RA) (11, 12) with a
lower TREC number especially in isolated CD4+ T cells (13),
multiple sclerosis with a decrease in TREC frequencies in both
CD4+ and CD8+ T cells (14, 15), systemic lupus erythematosus
(SLE) (15–17), and myasthenia gravis (18). These data suggest
that a disruption in thymic export might interfere with T cell
maturation and selection process, resulting in a premature output
of autoreactive or proliferation-impaired T cell clones (11).
The thymus is mostly active during the fetal period and
childhood and then begins to decrease in size and continues to
shrink with age, together with replacement of the epithelial tissue
by fat and connective tissue (19).
Group B coxsackieviruses (CV-B) belong to the Enterovirus
B species, Enterovirus genus, Picornaviridae family. The virus
particle is small, non-enveloped, and consists of a single-
stranded RNA genome with positive polarity encompassed in
an icosahedral capsid. The genome comprises a single open-
reading frame flanked by two untranslated regions at both the
5′ and 3′ ends [reviewed by Tracy et al., (20)]. Since CV-
B discovery, arguments of its association with induction or
acceleration of autoimmunity are accumulating. CV-B infections
may be involved in a variety of acute and chronic diseases that
have an autoimmune component, including myocarditis, dilated
cardiomyopathy, type 1 diabetes (T1D), encephalitis, thyroiditis,
or Sjögren’s syndrome [reviewed by Jaïdane et al., (21)].
In previous studies, CV-B4 infection of in vitro-cultured
murine thymic cells (22), human (23) and murine thymic
epithelial cells (24), human (25) and murine fetal thymic organ
cultures (FTOCs) (26), and the thymus of Swiss albino mice
inoculated through the oral route (27) was documented with
various effects. Briefly, the diabetogenic CV-B4 E2 persists in
primary cultures of human TECs with an increase of interleukin
(IL)-6, leukemia inhibitory factor (LIF), and granulocyte-
macrophage colony-stimulating factor (GM-CSF) (23). CV-B4
E2 is also able to infect human FTOC, inducing upregulation
of major histocompatibility complex (MHC) class I molecules
and severe depletion of thymocytes with anomalies in their
subpopulations (25). CV-B4 infection of murine FTOC also
disturbs the T lymphocyte maturation/differentiation process
(26). Chatterjee et al. (28) previously noticed such abnormalities
in thymocyte populations following inoculation of 5- to 6-week-
old male SJL/J mice by the same strain. Interestingly, CV-B4
E2 is able to reach the thymus during a systemic infection of
outbred Swiss albino mice inoculated through the oral route, and
its genome remains detectable up to 70 days post-inoculation
(27). CV-B4 E2, the prototype CV-B4 JVB, CV-B3, and echovirus
1 are able to persistently infect a murine TEC line with a drastic
decrease in the expression of insulin-like growth factor-2 (24).
Since thymic activity begins during fetal life, it is very likely
that a viral infection of the thymus could lead to its dysfunction.
Indeed, we recently demonstrated that CV-B4 E2 infects the
thymus in the course of in utero virus transmission, which
induces significant anomalies in thymic T cell subsets (21). In this
study, we used the same model of Swiss albino pregnant mice to
scrutinize the impact of in utero CV-B4 E2 infection on thymic
export by measuring different parameters.
MATERIALS AND METHODS
Virus
CV-B4 E2 strain (kindly provided by J. W. Yoon, Julia
McFarlane Diabetes Research Centre, Calgary, Alberta, Canada)
was propagated in human epithelial type 2 (HEp-2) cells
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(BioWhittaker, Walkersville, MD, USA) in Eagle’s minimum
essential medium (MEM; GIBCO BRL, Invitrogen, Gaithersburg,
MD, USA) supplemented with 10% heat-inactivated fetal calf
serum (FCS; GIBCO BRL), 2mM L-glutamine (BioWhittaker),
50µg/ml streptomycin, 50 IU/ml penicillin (GIBCO BRL),
and 2.5µg/ml Fungizone (amphotericin B; Apothecon).
Supernatants were collected 3 days after, submitted to three
cycles of freezing/thawing, then clarified by centrifugation at
4,000 × g for 10min, divided into aliquots and stored at −80◦C.
Viral titers in stocks were determined on HEp-2 cells by limiting
dilution assay for 50% tissue culture infectious dose (TCID50) by
the method of Reed and Muench (29).
Mating Protocol and Mice Inoculation
Eight- to 10-week-old female and male Swiss albino mice were
bred under standard conditions, with ad libitum water and food.
Four females per male were caged together, and the presence of a
vaginal plug was checked three times a day. The day the vaginal
plug was observed was considered as the first day of gestation
(day 1G).
Female mice were orally inoculated on the 10th or 17th day
of pregnancy with 2 × 106 TCID50 of CV-B4 E2 contained
in 200 µl MEM. Age-matched offspring from naive pregnant
mice served as mock-infected negative controls. Offspring were
weighed and euthanized with isoflurane at different time points
[near term (day 17G), the day of birth (referred to as day 1), and
day 5 after birth]. Thymus and spleen were removed, washed
with cold phosphate buffered saline (PBS), and weighed and
treated for TRECs and Ptk7 mRNA quantification. Each thymus
was cut into two halves: the first half (pool of three halves of
three different thymuses from three mice of the same litter)
was subjected to thymocyte isolation and then DNA extraction
for TREC quantification, and the second one was individually
(without pooling) subjected to RNA extraction for Ptk7 and viral
RNA quantification.
T Cell Receptor Rearrangement Excision
Circle Quantification
Cell Preparation and Lysis
A pool of a minimum of three thymuses or spleens from mice
of the same litter was mechanically digested, and the suspension
was pulsed by pipette to remove clumps. The suspension was
then washed with cold PBS [with 2% fetal calf serum (FCS)]
and filtered through a 70-µm MACS SmartStrainer (Miltenyi
Biotec). The obtained cells (thymocytes or splenocytes) were
then counted with Malassez cell with trypan blue exclusion of
dead cells.
To release their DNA content, 105 cells were lysed in lysis
buffer composed of Tris-HCl (10mM; pH 8.3), Tween 20
(0.05%), Igepal (0.05%), and proteinase K (100µg/ml) during
30min at 56◦C. Proteinase K was then inactivated at 95◦C during
10min, and samples were stored at−20◦C until proceeding.
Pre-PCR
sj and DβTRECs were co-amplified together with the CD4 gene
used as a single copy gene in a step called “pre-PCR,” using
outer (out) primers (Table 1). Briefly, 10 µl of cell lysates or
TABLE 1 | Primer sequences used in pre-PCR (Out) and T cell receptor
rearrangement excision circle quantification by multiplex real-time PCR (In).
Name Sequences
CD4 1 Out CCAACCAACAAGAGCTCAAGGA
In AGCTCAAGGAGACCACCATGT






















plasmids, containing sjTRECs (or DβTRECs) with CD4 inserts,
were added to 90 µl of a mix composed of 1 µl of each primer at
100mM, 20 µl of 5× colorless GoTaq R© Flexi buffer (Promega),
14 µl of MgCl2 (25mM, Promega), 4 µl of deoxynucleoside
triphosphate (dNTP, 10mM, Promega), 0.8 µl of GoTaq R© Flexi
DNA Polymerase (4U, Promega), and completed with nuclease-
free water (Ambion). Amplification was performed in an iCycler
thermocycler (Bio-Rad), and the PCR conditions were: initial
denaturation at 95◦C for 10min; 22 cycles of amplification each
consisting of 30 s at 95◦C, 30 s at 60◦C, and 2min at 72◦C,
followed by final elongation at 72◦C for 10min and cooling
at 20◦C.
sj and DβTREC Quantification
Total sjTREC number was estimated by quantification of δREC1
rearrangement with jα61 and jα58 segments since they represent
almost 100% of sjTREC frequency in mice (30). DβTREC content
was measured by quantifying Dβ1 rearrangements with Jβ1.1
to 1.6. The CD4 gene was used as a single copy gene, allowing
estimation of the number of cells (each cell possesses two alleles
of the CD4 gene, so the number of cells is equal to the number
of CD4 copies divided by 2). The relative numbers of copies
of CD4 gene and TRECs were obtained by multiplex nested
qPCR quantification by comparison with plasmids containing
both CD4 and sj61 or DJβ4 sequences respectively for sj or
DβTREC quantification.
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A real-time quantitative PCR assay to detect sj and DβTREC
sequences was developed based on amethod described byDulude
et al. (30).
Pre-PCR products were diluted 4,000× for CD4, 400× for
sj, and 100× for Dβ quantification both for thymus and spleen
samples, and relative CD4 and TREC number of copies were
determined by qPCR by adding 4 µl of diluted pre-PCR products
to 7 µl of TakyonTM No Rox SYBR MasterMix Blue dTTP
(Eurogentec), 0.2 µl of CD4 and TREC inner (In) primers
(purchased from Eurogentec; Table 1) each at 100mM, and
completed with nuclease-free water to reach a total volume of 14
µl. The amplification program was composed of 5min at 95◦C
for initial denaturation; 40 cycles of amplification each consisting
of 10 s at 95◦C, 15 s at 60◦C and 10 s at 72◦C, and cooling at 4◦C.
All reactions were run on a LightCycler 480 thermocycler (Roche
Diagnostics) and analyzed using the LightCycler 480 Software
by the second derivative max method. Samples were analyzed in
triplicate, which never varied by more than 10% from each other,
and the average of each sample was used. Standard curves with
determined numbers of copies were obtained by performing a
10-fold serial dilution of each plasmid. TREC levels are expressed
as TRECs per 106 cells. Copy numbers of TRECs and CD4 were
calculated by reporting the coefficient threshold (Ct) of each
sample to the standard curve.
Ptk7 Gene Expression
RNA Extraction
Total RNA was extracted from washed thymuses by the
acid guanidium thiocyanate–phenol–chloroform extraction
procedure using Tri-Reagent (Sigma, St. Louis, MO, USA),
precipitated with isopropanol, and washed with 75% ethanol as
described by Chomczynski and Sacchi (31). Sterile nuclease-free
water treated under the same extraction procedure served as a
negative control. The extracted RNA was dissolved in 30 µl of
nuclease-free water (Ambion), quantified using the Nanodrop
2000 (UV-Vis Spectrophotometer; Thermo Scientific, Waltham,
MA, USA), and submitted to DNase digestion, at 37◦C for
15min, by DNase type I (Roche) to eliminate contaminating
genomic DNA, followed by enzyme heat inactivation at 85◦C for
8min (32). The purified RNA was quantified again and stored at
−80◦C until use in reverse transcription (RT).
Complementary DNA Synthesis
RNA was reverse-transcribed using Moloney Murine Leukemia
Virus (M-MLV) Reverse Transcriptase (RT, Invitrogen).
Complementary DNA (cDNA) synthesis was performed with
∼500 ng of RNA in a final volume of 20 µl containing 20 U/µl
of RT, 2.5µM of anchored-oligo(dT)18 primer (Roche), 60µM
of random hexamer primer (Roche), 20U of RNase inhibitor
(Promega), and 1mM each dNTP.
According to the manufacturer’s instructions, secondary
structures were denatured by heating samples for 10min
at 65◦C in the presence of anchored-oligo(dT)18 primer,
random hexamer primer, dNTP mix, and water PCR grade
in a final volume of 20 µl. Samples were then cooled
on ice immediately, briefly centrifuged, supplemented with
5X First-Strand Buffer, 0.1M dithiothreitol (DTT) and 40U
of RNaseOUTTM Recombinant Ribonuclease Inhibitor, and
incubated at 37◦C for 5min. One microliter (200U) of M-MLV
RT was then added, and each sample was incubated at 25◦C for
10min followed by 50min at 37◦C. The enzyme was inactivated
by heating at 70◦C for 15min. Two negative controls were
performed in each reaction, one without RNA and the second
without the RT enzyme (RTminus control allowing the detection
of eventual genomic DNA contamination).
Quantitative PCR With SYBR Green
Real-time PCR was performed using 2X TakyonTM No Rox
SYBR R© MasterMix dTTP Blue (Eurogentec), Ptk7 forward
primer 5′-GCCGTGTGCCTTGAACCTC-3′, and Ptk7 reverse
primer 5′-CTCCACTTCACAACGGAGCA-3′ (Eurogentec).
Each reaction consisted of 20 µl containing 1 µl of cDNA, 10
µl of Takyon, and 3 pmol of each primer. The real-time qPCR
was run on an iCycler iQ real-time detection system (Bio-Rad)
using SYBR green detection. The cycling parameters were 95◦C
for 10min, followed by 40 cycles each consisting of denaturation
at 95◦C for 30 s, annealing at 60◦C for 30 s, and elongation at
72◦C for 25 s. A melting curve from 55 to 95◦C was performed
in each PCR reaction. The Ct was defined as the PCR cycle
number that crosses an arbitrarily placed signal threshold. All
samples were amplified in triplicate, and the mean was used for
further analysis. Each PCR reaction also included an RT minus
negative control to confirm the absence of genomic DNA and a
no-template negative control to check for primer-dimers.
A plasmid standard [128-pcDNA3.1 hygro(+)] containing
the target region was generated for each Ptk7 primer. The
amplified products were run on a 1% agarose gel to confirm
the specificity of the amplification, and products were cloned
using T4 DNA Ligase (Thermo Scientific). Plasmids were
isolated using the Wizard R© SV Gel and PCR Clean-Up
System (PROMEGA, Madison, USA) with DNA concentrations
determined by Nanodrop 2000 (Thermo Scientific). Standard
curves were obtained by using triplicate of 10-fold dilutions of
plasmid DNA. Copy numbers for each reaction were calculated
from the standard curves assuming that the average molecular
mass of a double-stranded DNA molecule is 650 Daltons.
Viral Load
One microliter of cDNA (generated from thymuses and
spleens as described above) was used to quantify CV-B4
RNA by qPCR with the same program as described for
Ptk7 gene. The primer sequences used were: forward primer
EV1 5′-CAAGCACTTCTGTTTCCCCGG-3′ and reverse primer
EV2 5′-ATTGTCACCATAAGCAGCCA-3′. Enterovirus 71 RNA
control (Vircell, Granada, Spain) was used as a standard for a
calibration curve containing five points ranging from 1.26 × 104
to 1.26 copies/ml.
Statistical Analysis
Statistical analysis was performed with GraphPad Prism 5
software version. The Mann–Whitney test was used for
cellularity, size, TREC, and Ptk7 analysis. A p value < 0.05 was
considered statistically significant. ∗p value < 0.05, ∗∗p value <
0.01, ∗∗∗p value < 0.001.
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FIGURE 1 | Thymus and spleen weight. Absolute and relative (organ weight/body weight) weights of thymus (A,B, respectively) and spleen (C,D, respectively) were
determined for coxsackievirus (CV) B4-infected and age-matched mock (•) thymuses and spleens, sampled at different time points, from fetuses at day 17 of
gestation (day 17G) and newborns at days 1 and 5 from birth. CV-B4 10G (H): thymus or spleen sampled from mice born to dams inoculated with CV-B4 at day 10 of
gestation; CV-B4 17G (): thymus or spleen sampled from mice born to dams inoculated with CV-B4 at day 17 of gestation. The Mann–Whitney test was used for
statistical analysis. n = 4–12 per group ***p < 0.0001, **p < 0.01, *p < 0.05.
RESULTS
Weight and Cellularity of Thymus and
Spleen Increased Following In utero
Coxsackievirus B4 Infection
In a first step, we compared weight and cell content of thymuses
and spleens of infected and control animals. Because of the small
weight and cellularity, values were also normalized in function
of total body weight (relative weight) or organ weight (relative
cellularity), respectively.
Effect of In utero Coxsackievirus B4
Infection on Organs’ Weight
In mock-infected mice, thymus absolute weight (in milligrams)
increased during development, especially after birth when it
tripled (p = 0.0005) when comparing days 5–1 (Figure 1A).
Following an infection at day 10G, the means of thymus absolute
weights were higher in virus-infected compared tomock-infected
mice at day 17G (3.975 vs. 1.967mg, respectively, p = 0.019)
and day 1 (6.382 vs. 3.6mg, respectively; p = 0.0019). Following
inoculation at day 17G, the increase was significant only at day 1
(4.617 vs. 3.6mg, p= 0.04). As shown in Figure 1B, when thymus
weight was corrected to matched body weight (relative thymus
weight), a significant difference was noted only at day 1, following
inoculation at day 10G (4 × 10−3 vs. 2.3 × 10−3, p = 0.0014) as
well as day 17G (3.2× 10−3 vs. 2.3× 10−3, p= 0.022).
The same profile was observed for the spleen absolute weight
(in milligrams) when comparing mock-infected mice at different
time points. Indeed, spleen absolute weight increased rapidly
during development. At day 5, the weight was 10- and 3-fold
higher than at days 17G and 1, respectively (Figure 1C). For mice
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FIGURE 2 | Thymus and spleen cellularity. Absolute and relative (number of cells/mg of cells) numbers of cells in the thymus (A,B, respectively) and spleen (C,D,
respectively) mice assessed by trypan blue exclusion test. Values were determined in coxsackievirus (CV)-B4-infected and age-matched mock (•) thymuses and
spleens, sampled at different time points, from fetuses at day 17 of gestation (day 17G) and newborns at days 1 and 5 from birth. CV-B4 10G (H): thymus or spleen
sampled from mice born to dams inoculated with CV-B4 at day 10 of gestation; CV-B4 17G (): thymus or spleen sampled from mice born to dams inoculated with
CV-B4 at day 17 of gestation. The Mann–Whitney test was used for statistical analysis. n = 6–8 per group ***p < 0.0001, **p < 0.01, *p < 0.05.
born to dams inoculated at day 10G, the increase in weight was
significant only at day 17G (3.117 vs. 0.95mg, p = 0.0007). On
the contrary, no significant difference was observed in spleen
weight of mice born to dams inoculated at day 17G (Figure 1C).
The relative spleen weight was significantly increased only at day
17G following an inoculation at day 10G when it was ∼3-fold
higher compared to matched controls (2.2 × 10−4 vs. 8 × 10−4,
respectively, p = 0.017). Inoculation at day 17G did not induce
any significant change in this parameter, neither at day 1 nor at
day 5 (Figure 1D).
Effect of In utero Coxsackievirus B4
Infection on Organs’ Cellularity
As described in the Materials and Methods section, the number
of cells in suspensions obtained from thymus and spleen was
counted, and viability was checked by trypan blue staining.
Viability was always higher than 95%. Evidently, cellularity
followed the same increase in weight, over time, in both tissues.
During development, the number of cells (×106) in the
thymus of mock-infected controls increased by 15-fold at day
1 and by 40-fold at day 5 compared to fetuses at day 17G. As
previously observed for absolute thymus weight, inoculation at
day 10G resulted in a significant increase in absolute cellularity
at day 17G (2.28 × 106 vs. 0.42 × 106, p = 0.0006), day 1
(9.47 × 106 vs. 5.043 × 106, p = 0.0021) and day 5 (17.3 ×
106 vs. 12.8 × 106, p = 0.041) compared to mock-infected mice.
A significant increase in thymus absolute cellularity was equally
noted following inoculation at day 17G, both at day 1 (7.87 ×
106 vs. 5.04 × 106, p = 0.009) and day 5 (16.71 × 106 vs. 12.8
× 106, p = 0.02) (Figure 2A). An increase in relative thymus
cellularity (cell number divided by thymus weight) was also noted
but with a significant difference only at day 17G (1.26 × 106/mg
of tissue vs. 0.185 × 106/mg of tissue, p = 0.0011) and day 1
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FIGURE 3 | Quantification of T cell receptor rearrangement excision circles (TRECs) as markers of thymopoiesis. The number/106 cells of sjTRECs and DβTRECs, as
well as sj/Dβ ratio, were quantified in thymocytes (A–C) and splenocytes (D–F) of age-matched controls (•) and coxsackievirus (CV) B4-infected thymuses and
spleens, sampled at different time points, from fetuses at day 17 of gestation (day 17G) and newborns at days 1 and 5 from birth. CV-B4 10G (H): thymus or spleen
sampled from mice born to dams inoculated with CV-B4 at day 10 of gestation; CV-B4 17G (): thymus or spleen sampled from mice born to dams inoculated with
CV-B4 at day 17 of gestation. The Mann–Whitney test was used for statistical analysis. n = 4–10 per group. ***p < 0.001, **p < 0.01, *p < 0.05. Data for spleen were
log-transformed before analysis.
(1.48× 106/mg of tissue vs. 0.97× 106/mg of tissue, p= 0.0012)
following an inoculation at day 10G and at both day 1 (2.174 ×
106/mg of tissue vs. 0.97× 106/mg of tissue, p= 0.0011) and day
5 (1.6× 106/mg of tissue vs. 1.125× 106/mg of tissue, p= 0.015)
following an inoculation at day 17G (Figure 2B).
The number of cells (×106) in the developing spleen of
mock-infected controls was 4- and 30-fold higher at days 1
and 5, respectively, than at day 17G. Following an infection, no
significant change was observed in absolute spleen cellularity,
except at day 17G in fetuses born to dams inoculated at day
10G (0.58 × 106 vs. 0.335 × 106, p = 0.031) (Figure 2C).
Relative spleen cellularity seemed slightly lower in CV-B4- than
in mock-infected mice, both at days 1 and 5, whatever mice were
inoculated at day 10G or at day 17G, and the difference was not
significant (Figure 2D).
sj and DβTRECs Decreased in Both
Thymus and Spleen Following In utero
Coxsackievirus B4 Infection
Intracellular sj and Dβ TREC levels were quantified in
thymocytes and in periphery in splenocytes by multiplex qPCR.
As shown in Figure 3A, the number of sjTRECs/106
thymocytes increased moderately during development in mock-
infected mice. An inverted pattern (decrease over time) was
observed following CV-B4 infection either at day 10G or 17G.
sjTREC frequencies were significantly decreased both at days
1 and 5 (133,700 vs. 204,300, p = 0.0147 and 150,900 vs.
214,600, p = 0.0147, respectively), following inoculation at day
10G. Following virus inoculation at day 17G, the difference was
significant (138,500 vs. 214,600, p = 0.0023) only at day 5 after
birth, with a decrease by 1.5-fold compared to controls.
As far as DβTREC frequencies in mock-infected control mice,
they increased gradually during development (2.5-fold at day 5
compared to day 17G). Analysis of the number of DβTRECs/106
thymocytes in infected animals revealed a significant decrease by
3.5-fold only at day 5 following CV-B4 inoculation either at day
10G or 17G (2,347 vs. 8,190, p = 0.0022 and 2,337 vs. 8,190, p
= 0.0006, respectively) (Figure 3B). Lower values in DβTRECs
were equally observed at days 17G and 1 following inoculation at
day 10G and at day 1 following inoculation at day 17G but did
not reach statistical significance.
The sj/DβTRECs ratio, as an indicator of intra-thymic
proliferation, presented the same value at days 17G and 1 with an
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FIGURE 4 | Ptk7 mRNA expression. RNA was converted by reverse transcription (RT), and the number of copies per 100 ng of RNA was determined in thymocytes of
age-matched controls (•) and coxsackievirus (CV) B4-infected mice by using a serial dilution of a reference plasmid. CV-B4 10G (H): thymus sampled from mice born
to dams inoculated with CV-B4 at day 10 of gestation; CV-B4 17G (): thymus sampled from mice born to dams inoculated with CV-B4 at day 17 of gestation. The
Mann–Whitney test was used for statistical analysis. n = 6–8 per group. ***p < 0.001, **p < 0.01, *p < 0.05. Data were log-transformed before analysis.
increase by 2-fold at day 5 (p = 0.0022) in mock-infected mice.
Following CV-B4 infection, no significant change was obtained
compared to control mice, whatever was the inoculation time,
except an increase by 2-fold (61.6 vs. 34.32, p = 0.0079) at day
17G following inoculation at day 10G (Figure 3C).
In the periphery, the number of sjTRECs/106 splenocytes
increased during development, especially at day 5 when it was
5-fold higher compared to days 17G and 1 (Figure 3D). Virus
inoculation either at day 10G or at day 17G did not induce any
significant effect at day 1. A significant decrease was however
observed at days 17G and 5 following inoculation at day 10G
(200.7 vs. 817.6, p = 0.0041 and 4,080 vs. 5,223, p = 0.0139,
respectively) and at day 5 following inoculation at day 17G (4,284
vs. 5,223, p= 0.0159).
As far as the number of DβTRECs/106 splenocytes in control
mice, it increased with development, by 2.5-fold at day 1 and
1.8-fold at day 5 compared to fetuses at day 17G. In infected
animals, a significant decrease was noted at the different studied
time points, whatever was the inoculation time (Figure 3E).
Indeed, compared to mock-infected mice, DβTREC frequencies
were more than 3-, 3.5-, and 5-fold lower at day 17G (20.13
vs. 58.14, p = 0.0045), day 1 (38.83 vs. 134.2, p = 0.0011),
and day 5 (25.86 vs. 127.7, p = 0.0006), respectively, in mice
born to dams inoculated at day 10G. Following inoculation
at day 17G, those frequencies were 6.3- and 5-fold lower at
day 1 (21.33 vs. 134.2, p = 0.0011) and day 5 (25 vs. 127.7,
p= 0.0006), respectively.
The sj/DβTREC ratio analysis in spleen of mock-infectedmice
shows that it followed the same profile as for sj and Dβ TRECs,
increasing by 5-fold at day 5 compared to day 17G. A significant
increase in the sj/DβTREC ratio was observed at day 5 following
an inoculation at day 10G (150 vs. 40.5, p = 0.0079) and at days
1 and 5 following an inoculation at day 17G (50.86 vs. 6.906, p=
0.0022 and 105.3 vs. 40.5, p= 0.004, respectively) (Figure 3F).
Ptk7 Gene Expression
Ptk7 expression level per 100 ng of total RNA in control
thymuses increased significantly during development at day 1
(p = 0.0449) and at day 5 (p = 0.015) compared to fetuses at
day 17G (Figure 4). It has a tendency to increase at day 17G
following CV-B4 inoculation at day 10G, then to decrease at day
1 following inoculation at either day 10G or 17G, even though
no statistically significant difference was found. That decrease
became significant at day 5 following inoculation at either at day
10G (3.45 × 108 vs. 4.5 × 108, p = 0.0012) or day 17G (3.85 ×
108 vs. 4.5× 108, p= 0.0025).
In utero Infection of Thymus and Spleen by
Coxsackievirus B4
The levels of CV-B4 RNA in offspring’s thymuses and spleens
were investigated by quantitative RT-PCR.
When the inoculation was performed at day 10G, 85% of
thymuses were positive, while about 40% of thymuses were
positive following inoculation at day 17G. Most elevated viral
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FIGURE 5 | Viral load in infected tissues. Thymocytes and splenocytes were sampled from fetuses at day 17 of gestation (day 17G) and from newborns at days 1 and
5 from birth, following an infection at day 10 or 17 of gestation (day 10G H or 17G). Total RNA was extracted, converted to cDNA, and the level of viral RNA in the
thymocytes (A) or splenocytes (B) was determined by qPCR and expressed as copy number per 100 ng of total RNA. n = 5–9 per group. Coxsackievirus (CV) B4
10G (H): thymus sampled from mice born to dams inoculated with CV-B4 at day 10 of gestation; CV-B4 17G (): thymus sampled from mice born to dams inoculated
with CV-B4 at day 17 of gestation. Data were log-transformed before analysis.
loads were recorded in samples at days 1 and 5 from offspring
born to dams inoculated at day 10G, ranging between 4× 104 and
9 × 104 copies per 100 ng of total RNA (Figure 5A). Thymuses
sampled from fetuses presented a lower level of CV-B4 RNA,
ranging from 2,073 to 8,215 copies, comparable to those from
offspring born to dams inoculated at day 17G and sampled at day
1 or 5.
Similarly to the thymus, ∼78% of spleens sampled from
offspring born to dams inoculated at day 10G were positive
against only 33% when inoculation was performed at day 17G.
The viral load in the spleen was lower and almost the same
following CV-B4 inoculation either at day 10G or 17G, ranging
from 1,440 to 8,440 copies, with only a slight increase at day
5 when it reached 14,707 copies per 100 ng of total RNA
(Figure 5B).
Intriguingly, by using the Spearman’s test, we could not
evidence any eventual correlation between the viral load in
the infected tissues and the observed variations among the
different analyzed parameters (weight, cellularity, TRECs, and
Ptk7 transcripts).
DISCUSSION
Studies focusing on viral infection of the fetal thymus are still
very rare. We have previously shown that CV-B4 reaches this
tissue in the course of an in utero infection and that such an
infection disturbs T cell differentiation (21). In this study, thymic
function was explored in pregnant Swiss albino (an outbred
strain which more accurately reflects natural variations inside
a population) mice that were orally inoculated by CV-B4 E2
at two different time points. As previously explained (33), the
CV-B4 E2 strain that we used was isolated by Yoon et al. (34)
but shares 99% homology with the E2 plaque-purified variant
of the CV-B4 Edwards strain already isolated by Kibrick and
Benirschke (35) from the myocardial tissue of a neonate who
suffered from encephalohepatomyocarditis (with focal necrosis
and inflammation of the pancreas) and died 36 h after birth. The
virus was vertically transmitted from mother to the infant based
on serological and virological evidence.
As described in the literature, the time of inoculation during
pregnancy influences the outcome of viral infection [as discussed
in our previous paper (36)]. We choose to inoculate mice
during the second (at day 10G) and the third week (at day
17G) of gestation, as we previously showed that inoculation at
those two different times induces significant changes in T cell
populations (21).
A wide array of immunological, cell surface, and molecular
markers was used for the assessment of thymic function
(37). Before delving into the molecular level, thymic function
was simply assessed through thymus and spleen weight and
cellularity. The choice of the spleen relies on the fact that it is
the most important secondary lymphoid organ and since it is the
simplest and easiest to sample at this early stage of development.
Thus, we observed that following in utero infection by CV-B4,
the thymus and spleen have grown in size and an increase in
cellularity was noted regardless the time of inoculation. This
suggests that CV-B4 infection induces thymic and peripheral
cellular proliferation and accumulation.
TRECs are generated as a by-product of the TCR
rearrangement process in the thymus and are enriched in
newly generated T cells (4). sj and DβTREC quantification was
the preferred tool as a surrogate marker for thymic export (7).
DβTRECs are precisely created at the DN2 stage, just before
the intensive T cell proliferation phase, and then, between the
DN4 stage and the DP stage, occurs the production of sjTRECs.
Accordingly, sj/DβTRECs ratio calculation allows the assessment
of intrathymic proliferation (30). Furthermore, in the study
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conducted by Dulude et al. (30), a strong positive correlation was
shown between the level of proliferation of the DN4 cell subset
in the thymus and the peripheral sj/DβTREC ratio.
Non-monotonic dynamics of the data is hard to interpret. sj
and DβTREC analysis in offspring showed a significant decrease
following CV-B4 infection compared to controls, a decrease that
gets worse as time goes by, both in the thymus and in the
spleen (periphery).
That decrease in TRECs at the thymus level vs. an increase
in cellularity may obviously be explained by an increased
proliferation and accumulation of thymocytes. Intriguingly,
the ratio of sj/Dβ being comparable to that in controls, we
should take more caution and consider several nonexclusive
explanations: (i) increased proliferation with a disturbance in
TCR chain rearrangement [temporary shift or rearrangement
did not achieve (did not occur at all, or was not successful
in generating TRECs, due to any blockade)] (ii) increased
proliferation with a disturbance in the maturation of thymocytes
[mainly a decrease in the DN subpopulation, as observed at
days 1 and 5 from birth, in our previous study (21)], (iii) a
blockade in thymic export, and (iv) an increase in the recruitment
of early thymic progenitor (ETPs) from BM and liver to the
thymus. During fetal life, in addition to the BM, the liver provides
T cell precursors that colonize the fetal thymus where their
maturation/differentiation takes place (38).
In the periphery, the detection of sjTRECs (markers of naive
T cells leaving the thymus, also called RTE) indicates thymic
export. Contrary to the thymus, a decrease of sj and Dβ TRECs
in the spleen vs. an expansion of the size can be explained by an
activation of cell proliferation following an infection. The sj/Dβ
TREC ratio confirms this hypothesis since it increased following
an infection compared to controls, with a positive correlation
with the viral load. This is in line with a previous suggestion
that a defect in thymic T cell production may be compensated
by increased self-replication of peripheral T cells (11). This
phenomenon consists of immune recovery through peripheral T
cell proliferation, therefore, recovery of thymic function, and it
was referred to as thymic rebound (39).
TREC assessment in the periphery was firstly conducted
in peripheral blood pooled from all mice of the same litter.
Additionally to the fact that at such an early age of life, blood
collection is not easily feasible, results of some analyzed samples
at days 1 and 5 showed a big discrepancy between samples in
the same conditions (results not depicted). A study conducted by
Elgbratt et al. (40), in colonic mucosa of patients with ulcerative
colitis, revealed that assessment of TREC levels in peripheral
blood is not informative.
The thymus is considered as a target organ for some viral
infections. Those infections can induce heavy consequences
such as a significant change in thymic weight and structure
and interference with thymic activity [reviewed by Nunes-
Alves et al., (41)]. A reduction in TREC level following human
immunodeficiency virus (HIV) (42), hepatitis C virus (HCV)
(43), and cytomegalovirus (CMV) (44) infections was previously
described. Increasing thymic volume together with a low sjTREC
level were described in peripheral blood mononuclear cells
(PBMCs) of HIV-positive patients after interruption of the highly
active antiretroviral therapy (45). Patients with higher thymic
volume had higher plasma viral load and a greater decline in
CD4+ cell count compared to patients with a lower viral load.
This was suggested as one of HIV strategies to increase the
number of available target cells (45). A significant reduction of
RTE, as assessed by coding joint (cj)TREC quantification, was
described in 14 patients with HCV infection compared to age-
matched controls (43). That deficit in RTE limits generation and
maintenance of a diverse TCR repertoire that is unable to provide
sufficient diversity for monitoring the infection and suppressing
of the virus (46). Low sjTREC values in PBMCs and higher
CMV loads were reported in patients with CMV infection (44).
Presence of autoreactive T cells in the periphery was associated
with both CMV infection and autoimmune diseases, namely, RA,
in the same patients (15).
Since Ptk7 expression declines with maturation and is no
longer expressed in RTEs, so it is judicious to analyze Ptk7
transcripts just in the thymus. The increase in Ptk7 gene
expression matches up with thymus size and development in
mock-infected mice, which is considered as an indicator of
a balance between T cell production and export. Absolute
quantification revealed a decrease in the expression of Ptk7
gene following an in utero CV-B4 infection. This reinforces the
hypothesis of a deficiency in the export of cells in a mature stage
(SP4 and SP8). This is in accordance with conclusions recently
drawn from our previous study (21) showing an increase in SP4 at
day 1 and in both SP4 and SP8 at day 5 following CV-B4 infection.
The opposite effect recorded at day 17G in the thymus for sj
and Ptk7, after inoculation at day 10G, is evocative of what we
previously observed with thymocyte subpopulations (21). In that
previous study, in utero infection by CV-B4 induced blockade
of DN to DP passage at day 17G. This can be explained by
the fact that sjTREC molecules are more precisely produced
at DN4 to DP transition (30), and it would be interesting
to characterize DN T cells. This is in line with our current
study since in utero infection of the thymus resulted in a
nonsignificant increase of Ptk7 gene expression in fetal thymus,
a gene mainly overexpressed by DN T cells. Let us remember
that Ptk7 gene expression declines progressively with maturation
until its repression in SP T cells in the thymus and shortly after
exportation in RTE SP4T cells (8–10).
Phenotypic characterization of T lymphocytes in the
periphery, precisely in the spleen, was assessed by flow cytometry
by using previously established phenotypic characteristics of
naive and memory T cells, identified as CD62L+CD44− or
CD62L−CD44+, respectively, for both SP4 and SP8. However,
as shown by TREC quantification, the number of T cells in the
periphery was very low, which prevented us from phenotyping
and quantifying both different cell categories (data not shown).
In utero infection of the spleen by CV-B4 was explored for the
first time. The less important effect recorded within the spleen
may be explained by lower viral loads.
Autoimmune disorders have a multifactorial etiology with
genetic, immunological, hormonal, and environmental factors
(47). A decrease in the influx of RTEs, therefore, a lower level
of TREC molecules, has been proposed as one of putative factors
that can lead to the pathogenesis of autoimmune diseases (48).
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TABLE 2 | Summary of significant differences (vs. mock) recorded for each of the different studied parameters.
Sampling Thymus Spleen Interpretation
Day 17G ↑ Weight*
↑ Cellularity*** and R. cellularity**
↑ sj/DβTREC**




Increased proliferation and accumulation
of thymocytes vs. decreased RTE and
increased proliferation in the periphery
Day 1 Inoculated at day 10G ↑ Weight** and R. weight**
↑ Cellularity** and R. cellularity**
↓ sj TREC*
↓ Dβ TREC** Disturbance in the maturation of
thymocytes and blockade in thymic export
vs. increased proliferation in the periphery
Inoculated at day 17G ↑ Weight* and R. weight*
↑ Cellularity** and R. cellularity**
↓ Dβ TREC**
↑ sj/Dβ TREC**
Accumulation of thymocytes vs. increased
proliferation in the periphery







Disturbance in the maturation of
thymocytes and blockade in thymic export
vs. decreased RTE but increased
proliferation in the periphery







Disturbance in the maturation of
thymocytes and blockade in thymic export
vs. decreased RTE but increased
proliferation in the periphery
***p < 0.001, **p < 0.01, *p < 0.05. RTE, recent thymic emigrant; TREC, T cell receptor rearrangement excision circle.
Indeed, a reduced thymic output vs. an excessive proliferation
of peripheral T cells was described in patients with acquired
RA (11, 12). Similar immunologic features were noted in SLE
patients by Kayser et al. (16). Indeed, patients with active SLE
presented a lower TREC levels in peripheral T cells, but not those
with quiescent disease (17). In patients with primary progressive
multiple sclerosis, reduced TREC level and thymic output were
observed and resulted in peripheral immune alterations and
clonal T cell expansions (49).
Abnormal T cell population dynamics can be a common
mechanism in autoimmune diseases and may be attributed to
viral infections (50). CV-B4 are very likely implicated in T1D
(51) and dilated cardiomyopathy (52). Both diseases are T cell
mediated and characterized by the recruitment of cytotoxic T
cells directed to CV-B antigens on the surface of β cells and
myocytes, leading to inflammation and organ injury (53–55).
Following infection, an increase in thymus weight and cellularity
vs. a low TREC level, could interfere with thymocyte maturation
and lead to escape from apoptosis resulting in a premature release
of T cells in the periphery. This may increase the possibility of
impaired selection and circulating of autoreactive T cell clones
which may hinder the maintenance of immune tolerance (48).
In conclusion, our results (summarized in Table 2) show a
significant decrease in TREC level in the thymus and spleen
(at days 1 and 5 from birth) following an in utero infection by
CV-B4. This infection also resulted in an increase in thymus
size, which could be explained by thymocyte proliferation but
with a disturbance in their TCR rearrangement and in their
maturation. Accumulation of thymocytes (mainly immature DP
cells, as suggested by the level of Ptk7 transcripts), reflecting
a defect in thymic export, should equally be considered. The
increase in spleen size, for its part, seems rather to be due
to an excessive proliferation as demonstrated by sj/Dβ TREC
ratio. Reduced thymic output and enhanced peripheral T cell
turnover could be one of the putative factors implicated in
CV-B-mediated automimmune pathogenesis. Disturbance in
T cell homeostasis may contribute to disequilibrium between
polyclonal and naive T cells and possibly to the presence of
oligoclonal memory autoreactive T cells which may interfere
with the maintenance of immune tolerance and lead to
autoimmune diseases.
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